Literature DB >> 4087269

Rifamycin SV in local treatment of synovitis--a clinical, arthroscopic and pharmacologic evaluation.

S Lindblad, E Hedfors, A S Malmborg.   

Abstract

Intraarticular injections of rifamycin SV were repeated weekly in patients with rheumatic disease with a chronic knee joint effusion. The clinical signs of synovitis were reduced in all, but disappeared in only one. A post injection reaction with transient local pain and effusion appeared at the third or a later injection in all the patients prompting withdrawal of 3. At these later injections local drug retention was shown by parallel determinations of rifamycin SV in synovial fluid and serum. The post treatment synovial fibrosis seen at arthroscopy could possibly explain the drug retention and the post injection inflammatory reaction. Thus, local treatment with rifamycin SV alleviated but rarely abolished synovitis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4087269

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

1.  Rifamycins inhibit human neutrophil functions: new derivatives with potential antiinflammatory activity.

Authors:  S Spisani; S Traniello; C Martuccio; O Rizzuti; L Cellai
Journal:  Inflammation       Date:  1997-08       Impact factor: 4.092

2.  3-(Carboxyalkylthio) rifamycin S and SV derivatives inhibit human neutrophil functions.

Authors:  S Spisani; S Traniello; A M Onori; O Rizzuti; C Martuccio; L Cellai
Journal:  Inflammation       Date:  1998-10       Impact factor: 4.092

3.  Vaccination with endosomal unknown epitopes produces therapeutic response in rheumatoid arthritis patients and modulates adjuvant arthritis of rats.

Authors:  Innocenzo Caruso; Salvatore Santandrea; Mariarita Gismondo; Alessandra Lombardi; Franco Montrone; Enzo Massimo Caruso; Piercarlo Sarzi Puttini
Journal:  J Transl Med       Date:  2016-06-07       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.